Author: admin

Semiconductor Chemical Market Size Analysis, Growth, Opportunities, Top Manufacturers, Share, Trends, Regional Analysis, and Forecast to 2028

“Browse 148 market data Tables and 48 Figures spread through 253 Pages and in-depth TOC on “Semiconductor Chemical Market””
The Semiconductor Chemical Market is thriving with advancements in electronics, driving demand for high-purity chemicals like etchants, dopants, and solvents. Growth is robust in Asia Pacific, North America, and Europe, propelled by technological innovations and expanding semiconductor manufacturing capacities.

The  Semiconductor chemical market size is projected to grow from USD 12.2 billion in 2023 to USD 21.9 billion by 2028, registering a CAGR of 12.3% during the forecast period. The semiconductor chemical market is experiencing robust growth due to several key factors and opportunities. Firstly, Technological developments in the semiconductor sector, rising demand for electronic devices, and rising demand for semiconductors across a broad range of businesses. The market presents a number of potential prospects, such as the creation of novel and enhanced semiconductor chemicals, the penetration of new markets, and development in the automotive and healthcare sectors.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191345076 

Semiconductor Chemicals Companies

The semiconductor chemical market is expected to continue to grow in the coming years due to the factors mentioned above. The key players in the market are focusing on developing new and innovative products to meet the growing demand. They are also expanding their geographic reach to tap into new markets.Players have adopted different strategies to strengthen their market positions and ensure long-term growth and success. These strategies enable them to efficiently meet the growing demand for types and applications by various industries. Also, companies operating in this market, such as Tokyo Ohka Kogyo Co., Ltd (Japan), JSR Corp (Japan), BASF SE (Germany), Solvay SA (Belgium), Dow, Inc (US) adopt acquisitions, new product launches, agreements, expansions, collaborations, and partnerships to increase their market shares and expand their geographic presence.

Founded in 1940, Tokyo Ohka Kogyo Co., Ltd. (TOK) is a company specializing in the manufacturing and sale of chemical and manufacturing materials. TOK has established itself as an R&D-focused enterprise at the forefront of fine chemical development. Over the years, the company has expanded its expertise from high-purity chemicals to cutting-edge high-performance photoresists for photosensitive materials. The Materials segment offers an extensive array of photoresists and high-purity chemicals, essential components extensively utilized in the production of semiconductors, liquid crystal displays (LCDs), semiconductor packaging, and various electronic products. In addition, the Equipment segment encompasses a range of machinery and equipment, including photoresist coating and developing machines crucial in the manufacturing of LCD (Liquid Crystal Display) panels. This segment also encompasses a diverse selection of semiconductor manufacturing equipment designed to facilitate various stages of semiconductor production.  The company possesses foundational technologies such as Microfabrication Technology and High-Purification Technology. With its headquarters based in Japan, TOK has a global presence, serving regions such as Asia, the Pacific, North America, and Europe. As of the year 2022, the company’s workforce comprises 1,950 employees.

JSR Corp., headquartered in Tokyo, Japan, is a company engaged in the manufacturing and sale of synthetic rubber and fine chemical materials. The company operates through several distinct segments, each serving specific markets and industries. The four segments are Digital Solutions, Plastics, Life Sciences and Others. The Digital Solution segment is involved in the production and marketing of materials crucial to the semiconductor, display, and optical industries. In the Life Science segment, JSR handles a range of products, including diagnostics, research reagents, related materials, and provides services for bio process manufacturing and development. JSR Corp., established in 1957, has diversified its operations across these segments to serve a wide array of industries with its synthetic rubber and chemical materials, making it a significant player in the global market. JSR Corp. maintains a global presence with operations spanning across Europe, the Asia-Pacific region, as well as North and Central America. In the year 2023, the company’s workforce comprises 7,994 employees. Multiple official sources in 2023 are reporting that Japan, with the support of a government-backed fund, has reached an agreement to acquire JSR Corp, for approximately $6.4 billion.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=191345076 

Founded in 1865, BASF SE is headquartered in Ludwigshafen am Rhein, Germany, and has established itself as a prominent player in the global chemical industry, serving various sectors with its diverse product offerings. BASF SE is a leading provider of chemical products with a diverse business portfolio. The company operates across several segments, each catering to distinct industries. These segments include Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition and Care, and Agricultural Solutions. In the Chemicals segment, BASF supplies petrochemicals and intermediates, serving as a key player in the chemical industry. The Materials segment encompasses isocyanates, polyamides, inorganic basic products, and specialty chemicals tailored for the plastics and plastics processing sectors. The Industrial Solutions segment focuses on the development and marketing of ingredients and additives essential for industrial applications. This includes polymer dispersions, pigments, resins, electronic materials, antioxidants, and various additives. The Surface Technologies segment combines chemical solutions for surfaces with divisions dedicated to catalysts and coatings. This segment offers comprehensive solutions for surface treatment needs. Within the Nutrition and Care segment, BASF provides ingredients and solutions designed for consumer applications spanning nutrition, home products, and personal care items. Lastly, the Agricultural Solutions segment encompasses a wide range of agricultural products, including fungicides, herbicides, insecticides, biological crop protection products, as well as seeds and seed treatment products. The company has a worldwide presence in all major regions.

Solvay SA is a prominent player in the manufacturing and distribution of chemical and plastic products. Solvay SA, established by Ernest Solvay in 1863, is headquartered in Brussels, Belgium, and remains a prominent player in the chemical and plastics industry with a global reach and diversified product portfolio. The company’s operations are structured into several key segments Solutions, Advanced Materials and Chemicals. The Advanced Materials segment focuses on providing advanced materials suitable for a wide range of applications, notably in the automotive, aerospace, electronics, and health sectors, catering to the evolving needs of these industries. In the Solutions segment, Solvay offers a distinct array of specialized formulations and leverages its application expertise to create customized solutions that impact surface chemistry and liquid behavior. These tailor-made formulations are designed to optimize yield and efficiency while concurrently minimizing the environmental impact. The Chemicals segment, on the other hand, operates in well-established and robust markets. Within this segment, Solvay holds strategic positions in chemical intermediates, which contribute significantly to its sustained and stable presence in the market. The company has regional presence worldwide.

Founded in 1897, Dow is headquartered in Midland, Michigan,US and continues to be a leading player in the materials science sector. Dow, Inc. is a leading materials science company specializing in the development of innovative solutions. The company operates through three key segments: Packaging and Specialty Plastics, Industrial Intermediates and Infrastructure, and Performance Materials and Coatings. The Packaging and Specialty Plastics segment encompasses hydrocarbons, energy, and packaging, along with specialty plastics. In the Industrial Intermediates and Infrastructure segment, Dow provides a range of industrial solutions, polyurethanes, and construction chemicals. Notably, this segment also includes the supply of chemicals for the electronics industry. The Performance Materials and Coatings segment focuses on coatings, performance monomers, and consumer solutions. The company is having presence in all major regions like Asia-Pacific, Europe, North America, South America and Middle East and Africa.

Inquire Now: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=191345076

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.  

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/semiconductor-chemical-market-191345076.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Semiconductor Chemical Market Size Analysis, Growth, Opportunities, Top Manufacturers, Share, Trends, Regional Analysis, and Forecast to 2028

Metal Recycling Market Size, Opportunities, Top Companies, Growth, Trends, Regional Graph, Key Segments, and Forecast to 2029

“Browse 391 market data Tables and 53 Figures spread through 298 Pages and in-depth TOC on “Metal Recycling Market””
The Metal Recycling Market is expanding globally, driven by increasing environmental awareness and resource efficiency. Significant growth is observed in North America, Europe, Asia Pacific, and emerging markets, fueled by industrial demand and regulatory support for sustainable practices.

The metal recycling market size is projected to grow from USD 551.9 billion in 2024 and is projected to reach USD 767.9 Billion by 2029, at a CAGR of 6.8%. The metal recyclings market is witnessing a significant surge, largely propelled by environmental sustainability, regulatory requirements, resource conservation, economic incentives, and advancements in recycling technology. The Asia Pacific region, particularly China, stands out as the fastest-growing market due to its large manufacturing sector generates significant metal scrap, driving the demand for recycling.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102425671  

The key players in the metal recycling market are The Arc welding torch market comprises key manufacturers such as are ArcelorMittal (Luxembourg),  Nucor (US), CMC (US), Sims Limited (Australia), Aurubis AG (Germany), Dowa Holdings Co., Ltd. (Japan), Tata Steel (India), Radius Recycling, Inc. (US),  European Metal Recycling Ltd. (UK), and  Upstate Shredding – Weitsman Recycling (US) among others. These players have adopted various strategies, such as merger & acquisition, investment & expansion, new product launch, and contract & agreement between 2019 and 2024, to enhance their market shares and expand their global presence.

ArcelorMittal, a prominent steel and mining corporation globally, emerged in 2007 following the merger of Mittal Steel Company N.V. and Arcelor, which had both grown significantly through various acquisitions over the years. As the largest steel producer in Europe and among the top players in the Americas, ArcelorMittal extends its reach into Asia, particularly India, through the joint venture AMNS India. Operating steel-making facilities across 15 nations, including 37 integrated and mini-mill plants, ArcelorMittal caters primarily to local markets and serves a diverse range of industries in about 140 countries, such as automotive, appliance, engineering, construction, and machinery.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=102425671 

Nucor Nucor is a company that produces steel and steel-related products. It also processes ferrous and nonferrous metals. Nucor is a well-known recycler in North America that primarily uses scrap steel as its major raw material for the manufacturing of steel and steel products. Steel mills, steel products, and raw materials are the three main business segments in which the company operates. In the steel mills business, Nucor maintains an effective inventory management to satisfy expected demands and custom produces hot-rolled, cold-rolled, and galvanised sheet steel to meet specific customer specifications. Both ferrous and non-ferrous scrap metal are handled by the company in its raw materials section. The finished metal is either sold to outside clients or used in the steel mill segment. Nucor also provides material processing and transportation services to scrap metal consumers. Ferrous scraps are supplied to foundries and electric and furnace steel mills, while non-ferrous scraps are sent to aluminium can manufacturers, smelters and steel mills. The David J. Joseph Company (DJJ), a fully owned subsidiary of Nucor, leads the industry in ferrous and nonferrous metal recycling, transportation services, and scrap metal brokerage. DJJ has the ability to sort and recycle more than 5 million tonnes of ferrous and nonferrous scrap annually. DJJ operates 70 scrap recycling facilities and 6 regional businesses around the US.

CMC produces, recycles, and markets steel and metal products along with its subsidiaries. It maintains a vast and well-established global network of steel mills, fabrication, processing, recycling, and construction product warehouses as well as distribution offices.  CMC operates within two main segments: North America and Europe. The North American segment is comprised of a network of recycling facilities, steel mills, and fabrication businesses. In the meanwhile, the Europe sector consists of a Polish fabrication facility, an EAF micro mill, and a network of recycling facilities.

  • In March 2023, ArcelorMittal successfully acquired Companhia Siderúrgica do Pecém (“CSP”) (renamed ArcelorMittal Pecém) in Brazil after obtaining all necessary regulatory approvals with the deal size USD 2.2 billion.
  • In January 2023, Nucor finalized the investment of around   USD 650 million to enhance and expand production capacity at its Gallatin flat-rolled sheet mill in Ghent, Kentucky. This project has boosted the mill’s production capability from roughly 1,600,000 tons to about 2,800,000 tons annually.
  • In July 2023, CMC declared that it received a permit from the West Virginia Department of Environmental Protection, enabling the commencement of construction for its fourth state-of-the-art micro mill. This permit marks a significant milestone in its Steel West Virginia micro mill project.
  • In August, 2023, Sims Metal announced its agreement to purchase the assets of Baltimore Scrap Corp (BSC), a metal recycler based in the US, along with its affiliated entities. The acquisition is expected to be finalized in October 2023, pending the fulfillment or waiver of standard closing conditions, including necessary regulatory clearances.

Inquire Now: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=102425671 

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/metal-recycling-market-102425671.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Metal Recycling Market Size, Opportunities, Top Companies, Growth, Trends, Regional Graph, Key Segments, and Forecast to 2029

Myc Proto Oncogene Protein Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Biogenera SpA, Ceptur Therapeutics Inc, Cothera Bioscience

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myc Proto Oncogene Protein pipeline constitutes key companies continuously working towards developing Myc Proto Oncogene Protein treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

“Myc Proto Oncogene Protein Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Myc Proto Oncogene Protein Market.

 

The Myc Proto Oncogene Protein Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

 

Some of the key takeaways from the Myc Proto Oncogene Protein Pipeline Report: 

  • Companies across the globe are diligently working toward developing novel Myc Proto Oncogene Protein treatment therapies with a considerable amount of success over the years. 

  • Myc Proto Oncogene Protein companies working in the treatment market are Linnane Pharma, Peptomyc, Moleculin Biotech, Cothera Bioscience, EpicentRx, and others, are developing therapies for the Myc Proto Oncogene Protein treatment 

  • Emerging Myc Proto Oncogene Protein therapies in the different phases of clinical trials are- MYC degrader, OMO- 103, WP-1066, PC 002, RRx-001, and others are expected to have a significant impact on the Myc Proto Oncogene Protein market in the coming years.   

  • In August 2022, EpicentRx has launched a trial named “REPLATINUM: A Phase 3, Controlled, Open-label, Global Randomized Study” to investigate the sequential administration of RRx-001 with a platinum doublet compared to a platinum doublet alone in treating Small Cell Lung Cancer patients in their third line of treatment or later. This global Phase 3 study aims to determine the potential superiority of RRx-001 combined with platinum chemotherapy over platinum chemotherapy alone for advanced-stage small cell lung cancer.

 

Myc Proto Oncogene Protein Overview

The Myc proto-oncogene protein, often referred to simply as c-Myc, is a transcription factor encoded by the MYC gene in humans. It plays a crucial role in regulating the expression of numerous genes involved in cell growth, proliferation, differentiation, and apoptosis (programmed cell death). Dysregulation or overexpression of c-Myc is commonly associated with various cancers, where it contributes to tumor initiation, progression, and metastasis.

 

Get a Free Sample PDF Report to know more about Myc Proto Oncogene Protein Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/myc-proto-oncogene-protein-pipeline-insights

 

Emerging Myc Proto Oncogene Protein Drugs Under Different Phases of Clinical Development Include:

  • MYC degrader: Linnane Pharma

  • OMO- 103: Peptomyc

  • WP-1066: Moleculin Biotech

  • PC 002: Cothera Bioscience

  • RRx-001: EpicentRx

 

Route of Administration

Myc Proto Oncogene Protein pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Intra-articular

  • Intraocular

  • Intrathecal

  • Intravenous

  • Oral

  • Parenteral

  • Subcutaneous

  • Topical

  • Transdermal

 

Molecule Type

Products have been categorized under various Molecule types such as

  • Oligonucleotide

  • Peptide

  • Small molecule

 

Myc Proto Oncogene Protein Pipeline Therapeutics Assessment

  • Myc Proto Oncogene Protein Assessment by Product Type

  • Myc Proto Oncogene Protein By Stage and Product Type

  • Myc Proto Oncogene Protein Assessment by Route of Administration

  • Myc Proto Oncogene Protein By Stage and Route of Administration

  • Myc Proto Oncogene Protein Assessment by Molecule Type

  • Myc Proto Oncogene Protein by Stage and Molecule Type

 

DelveInsight’s Myc Proto Oncogene Protein Report covers around products under different phases of clinical development like

  • Late-stage products (Phase III)

  • Mid-stage products (Phase II)

  • Early-stage product (Phase I)

  • Pre-clinical and Discovery stage candidates

  • Discontinued & Inactive candidates

  • Route of Administration

 

Further Myc Proto Oncogene Protein product details are provided in the report. Download the Myc Proto Oncogene Protein pipeline report to learn more about the emerging Myc Proto Oncogene Protein therapies

 

Some of the key companies in the Myc Proto Oncogene Protein Therapeutics Market include:

Key companies developing therapies for Myc Proto Oncogene Protein are – Biogenera SpA, Ceptur Therapeutics Inc, Cothera Bioscience Pty Ltd, Erasca Inc, Phylogica Limited, Dicerna Pharmaceuticals, Inc., Sorrento Therapeutics, Inc, Anima Biotech Inc, Arrakis Therapeutics Inc, Arvinas Inc, Escend Pharmaceuticals Inc, Gibson Oncology LLC, and Kintor Pharmaceutical, and others.

 

Myc Proto Oncogene Protein Pipeline Analysis:

The Myc Proto Oncogene Protein pipeline report provides insights into 

  • The report provides detailed insights about companies that are developing therapies for the treatment of Myc Proto Oncogene Protein with aggregate therapies developed by each company for the same.

  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Myc Proto Oncogene Protein Treatment.

  • Myc Proto Oncogene Protein key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

  • Myc Proto Oncogene Protein Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 

  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Myc Proto Oncogene Protein market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

 

Download Sample PDF Report to know more about Myc Proto Oncogene Protein drugs and therapies

 

Myc Proto Oncogene Protein Pipeline Market Drivers

  • Technological advancements toward cMyc-Max Inhibition, growing interest of Pharma and research community to develop different strategies to target cMycproteins are some of the important factors that are fueling the Myc Proto Oncogene Protein Market.

 

Myc Proto Oncogene Protein Pipeline Market Barriers

  • However, undesirable side effects on normal cells, lack of approved therapies and other factors are creating obstacles in the Myc Proto Oncogene Protein Market growth.

 

Scope of Myc Proto Oncogene Protein Pipeline Drug Insight    

  • Coverage: Global

  • Key Myc Proto Oncogene Protein Companies: Linnane Pharma, Peptomyc, Moleculin Biotech, Cothera Bioscience, EpicentRx, and others

  • Key Myc Proto Oncogene Protein Therapies: MYC degrader, OMO- 103, WP-1066, PC 002, RRx-001, and others

  • Myc Proto Oncogene Protein Therapeutic Assessment: Myc Proto Oncogene Protein current marketed and Myc Proto Oncogene Protein emerging therapies

  • Myc Proto Oncogene Protein Market Dynamics: Myc Proto Oncogene Protein market drivers and Myc Proto Oncogene Protein market barriers 

 

Request for Sample PDF Report for Myc Proto Oncogene Protein Pipeline Assessment and clinical trials

 

Table of Contents

1. Myc Proto Oncogene Protein Report Introduction

2. Myc Proto Oncogene Protein Executive Summary

3. Myc Proto Oncogene Protein Overview

4. Myc Proto Oncogene Protein- Analytical Perspective In-depth Commercial Assessment

5. Myc Proto Oncogene Protein Pipeline Therapeutics

6. Myc Proto Oncogene Protein Late Stage Products (Phase II/III)

7. Myc Proto Oncogene Protein Mid Stage Products (Phase II)

8. Myc Proto Oncogene Protein Early Stage Products (Phase I)

9. Myc Proto Oncogene Protein Preclinical Stage Products

10. Myc Proto Oncogene Protein Therapeutics Assessment

11. Myc Proto Oncogene Protein Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Myc Proto Oncogene Protein Key Companies

14. Myc Proto Oncogene Protein Key Products

15. Myc Proto Oncogene Protein Unmet Needs

16 . Myc Proto Oncogene Protein Market Drivers and Barriers

17. Myc Proto Oncogene Protein Future Perspectives and Conclusion

18. Myc Proto Oncogene Protein Analyst Views

19. Appendix

20. About DelveInsight

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: India
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Myc Proto Oncogene Protein Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Biogenera SpA, Ceptur Therapeutics Inc, Cothera Bioscience

The Healthcare Logistics Market to Hit $290.73 Billion by 2029, Driven by High Adoption of Cloud-based Enterprise Resource Planning (ERP) Systems – Arizton

“Healthcare Logistics Market Research Report by Arizton”

According to Arizton’s latest research report, the healthcare logistics market is growing at a CAGR of 7.75% during 2023-2029.  

 

To Know More, Click: https://www.arizton.com/market-reports/healthcare-logistics-market-size-analysis 

 

Report Summary  

Market Size (2029): $290.73 Billion  

Market Size (2023): $185.77 Billion 

CAGR (2023-2029): 7.75%  

Historic Year: 2020-2022 

Base Year: 2023 

Forecast Year: 2024-2029 

Market Segmentation: Product, Functionality, End-user, and Geography 

Geographical Analysis: North America, Europe, APAC, Latin America, and Middle East & Africa 

 

Stay ahead of the curve with Arizton’s exclusive subscription plan, offering in-depth analysis, market sizing, and growth forecasts for less than $900 per month—a significant value compared to individual report purchases. Click here: https://www.arizton.com/subscription     

 

The market is growing at a steady pace, and this trend is likely to continue during the forecast period due to the growing market for temperature-sensitive drugs and biological clinical materials, combined with increasing awareness among pharmaceutical and logistics enterprises, is amplifying the potential for temperature-controlled healthcare logistics, thereby benefiting the entire healthcare logistics market. 

 

Healthcare Facilities in End User Segment to Witness Fastest Growth Rate  

The healthcare facilities segment is projected to grow at a CAGR of 8% to reach $90.42 billion by 2029. In 2023, the healthcare facilities segment accounted for 30.67% of the global healthcare logistics market. This growth trend, with an absolute increase of 58.72%, includes hospitals, urgent care units, doctor’s offices, nursing homes, and ambulatory surgical centers. As the healthcare system becomes more complex, patients have more options for their care, increasing the demand for efficient healthcare logistics. Logistics are crucial for healthcare facilities, providing delivery, transportation, warehousing, and value-added services to ensure timely medical supplies. Strategic partnerships with third-party logistics (3PL) providers like DHL, UPS, Yusen Logistics, and Nippon Express help minimize healthcare costs while maintaining high-quality service standards. These collaborations allow healthcare companies to leverage streamlined processes, advanced technology, and infrastructure, reducing wastage and inefficiencies in the supply chain and achieving significant cost reductions. 

 

Market Trends 

M&A Strategies Expanding Healthcare into Non-Acute Settings  

The shift towards non-acute care settings represents a fundamental transformation in healthcare delivery, driven by the need to improve access, reduce costs, and enhance patient outcomes. Ambulatory surgery centers, community clinics, and home care services offer more convenient and less expensive alternatives to traditional hospital-based care, particularly for routine procedures and chronic disease management. Mergers and acquisitions are significant in this transition as healthcare organizations seek to expand their reach and capabilities by integrating non-acute services into their networks. For example, a health system may acquire a local hospital that operates ambulatory surgery centers or a network of clinics, allowing for better coordination of care and improved patient access across the continuum. The move towards non-acute care settings and preventative care reflects a broader shift towards value-based healthcare models prioritizing patient-centered, holistic wellness approaches. Through strategic M&A activities and targeted initiatives, healthcare organizations aim to create more efficient, equitable, and sustainable healthcare systems that meet the diverse needs of patients and communities. 

Adoption of Cloud-based Enterprise Resource Planning (ERP) Systems  

Adopting cloud-based enterprise resource planning (ERP) systems in the healthcare supply chain has significantly improved data management practices. These systems serve as centralized hubs for storing and managing vast amounts of data related to inventory, procurement, distribution, and other supply chain activities. One of the key benefits of cloud-based ERP systems is their ability to integrate data from various sources into a single, unified platform. This integration facilitates real-time visibility into inventory levels, demand patterns, and supply chain performance metrics across multiple facilities and locations. With all relevant data accessible from a centralized location, supply chain managers can make informed decisions quickly and efficiently. 

Furthermore, cloud-based ERP systems enable the deployment of advanced technologies such as artificial intelligence (AI) and machine learning (ML). These technologies leverage the rich data stored in the ERP system to drive predictive analytics and optimization algorithms. For example, AI and ML algorithms can analyze historical demand patterns to forecast future inventory needs more accurately, helping organizations optimize stock levels and reduce the risk of stockouts or excess inventory. Moreover, AI-powered analytics can identify potential disruptions in the supply chain, such as delays in product delivery or fluctuations in demand, allowing supply chain managers to proactively address these issues before they escalate. By leveraging AI-driven insights, healthcare organizations can improve supply chain resilience, minimize risks, and enhance operational efficiency. 

 

Buy this Research @ https://www.arizton.com/market-reports/healthcare-logistics-market-size-analysis 

 

Key Vendors 

  • Cencora 

  • CEVA Logistics 

  • FedEx 

  • Kuehne + Nagel 

  • DB Schenker 

  • Deutsche Post DHL Group 

  • United Parcel Service (UPS) 

  • AWL 

  • Alloga 

  • Bollore Logistics 

  • Cardinal Health 

  • C.H. Robinson 

  • Cold Chain Technologies (CCT) 

  • DSV 

  • Farmasoft 

  • Lufthansa Cargo 

  • Medline 

  • Nippon Express Co. Ltd 

  • Oximio 

  • SEKO Logistics 

  • Sinotrans Limited 

  • XPO Logistics 

  • ZirconMed 

  • GXO 

  • ArcBest 

  • Associated Couriers 

  • Carousel Logistics 

  • Crane Worldwide Logistics 

  • CRYOPDP 

  • DACHSER 

  • Expeditors 

  • Freight Logistics Solutions 

  • Global Group 

  • Kenco 

  • Kerry Logistics Network 

  • Kintetsu World Express 

  • Life Science Logistics 

  • Mercury 

  • Nissin International Logistics Provider 

  • Rhenus Logistics 

  • Geodis 

 

Segmentation & Forecast 

  • By Product Type 

  • Pharmaceuticals 

  • Medical Devices 

  • By Functionality 

  • Transportation 

  • Road 

  • Water 

  • Air 

  • Warehousing 

  • Others 

  • By End-user 

  • Pharmacies 

  • Healthcare Facilities 

  • Diagnostic Laboratories 

  • Others 

 

Geography 

  • North America 

  • The U.S. 

  • Canada 

  • Europe 

  • Germany 

  • The U.K. 

  • France 

  • Italy 

  • Spain 

  • APAC 

  • Japan 

  • China 

  • India 

  • Australia 

  • South Korea 

  • Latin America 

  • Brazil 

  • Mexico 

  • Argentina 

  • Middle East & Africa 

  • Turkey 

  • South Africa 

  • Saudi Arabia 

 

Key Questions Answered in the Report:  

What are the key trends in the global healthcare logistics market? 

Which region dominates the global healthcare logistics market? 

How big is the global healthcare logistics market? 

Who are the major players in the global healthcare logistics market? 

What is the growth rate of the global healthcare logistics market? 

 

Check Out Some of the Top Selling Reports of Your Interest:  

U.S. Tele-Intensive Care Unit Market – Focused Insights 2024-2029 

https://www.arizton.com/market-reports/us-tele-intensive-care-unit-icu-market 

Global Healthcare Supply Chain Management Market – Focused Insights 2024-2029 

https://www.arizton.com/market-reports/healthcare-supply-chain-management-market 

 

Why Arizton?                             

100% Customer Satisfaction                             

24×7 availability – we are always there when you need us                             

200+ Fortune 500 Companies trust Arizton’s report                             

80% of our reports are exclusive and first in the industry                             

100% more data and analysis                             

1500+ reports published till date           

 

Post-Purchase Benefit                         

  • 1hr of free analyst discussion                         

  • 10% off on customization      

 

About Us:                                                                  

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                                

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                                 

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                                       

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1-312-235-2040 / +1 302 469 0707    
Country: United States
Website: https://www.arizton.com/market-reports/healthcare-logistics-market-size-analysis

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Healthcare Logistics Market to Hit $290.73 Billion by 2029, Driven by High Adoption of Cloud-based Enterprise Resource Planning (ERP) Systems – Arizton

Guy Monseair Featured in an Exclusive Interview on Kivo Daily: Shaping Future Leaders through Rowing

Guy Monseair Featured in an Exclusive Interview on Kivo Daily: Shaping Future Leaders through Rowing

Guy Monseair, Bronx, NY

Guy Monseair, the highly respected Head Coach and Executive Director at City Island Rowing, recently shared his insights in an exclusive interview with Kivo Daily. With a rich background in both the arts and entrepreneurship, Monseair has transitioned into a pivotal role in the athletic and personal development of young rowers, emphasizing holistic growth alongside athletic excellence.

In the interview, Monseair discusses his unexpected journey from managing art galleries and horticulture ventures to discovering his passion for coaching. He highlights how the skills gained in business have seamlessly translated into creating structured, goal-oriented training environments that benefit his rowing teams. Monseair’s approach goes beyond physical training, integrating mental health workshops, leadership development, and community service to foster well-rounded athletes.

A significant focus of the discussion is how rowing is an exceptional sport for developing future leaders. Monseair explains, “Rowing combines physical prowess with intense teamwork and strategic thinking, which are all critical for leadership.” He also discusses the importance of maintaining a balance between athletics and academics, ensuring his athletes succeed in all areas of their lives.

Monseair also touches upon the role of nutrition and recovery in sports, underscoring the importance of a well-rounded approach to athlete health, which enhances performance and minimizes injuries. One memorable highlight from his coaching career, as shared in the interview, was leading his team to a national championship, a testament to the hard work and unity of his athletes.

Furthermore, Monseair offers invaluable advice for aspiring coaches, emphasizing continuous learning and genuine care for athletes’ development. Looking ahead, he is excited about new initiatives at City Island Rowing, including expanding community outreach programs and integrating environmentally sustainable practices into their training facilities.

This comprehensive interview provides profound insights into the philosophy and strategies of one of rowing’s most influential coaches, demonstrating how sports can be a powerful platform for shaping the leaders of tomorrow.

About Guy Monseair 

Guy Monseair is the esteemed Head Coach and Executive Director at City Island Rowing in Bronx, NY. His diverse background includes entrepreneurship in art galleries and horticulture, ultimately leading him to his true passion: coaching. At City Island Rowing, Guy not only fosters athletic excellence but also emphasizes the holistic development of young athletes, preparing them for success both on and off the water.

To read the full interview, click here.

Media Contact
Contact Person: Guy Monseair
Email: Send Email
City: Bronx
State: New York
Country: United States
Website: https://www.guymonseair.com/

Severe Asthma Pipeline 2024 | Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier Biotherapeutics, Kymera

DelveInsight’s, “Severe Asthma Pipeline Insight 2024” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Severe Asthma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Discover the latest drugs and treatment options in the Severe Asthma Pipeline. Dive into DelveInsight’s comprehensive report today! @ Severe Asthma Pipeline Outlook

 

Key Takeaways from the Severe Asthma Pipeline Report

  • July 2024:- Incyte Corporation– A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma. The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
  • July 2024:- Amgen- A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma. The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.
  • DelveInsight’s Severe Asthma Pipeline analysis depicts a robust space with 50+ active players working to develop 55+ pipeline treatment therapies.
  • The leading Severe Asthma Companies such as Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier Biotherapeutics, Kymera Therapeutics, Suzhou Connect Biopharmaceuticals, Upstream Bio, Teva Branded Pharmaceutical Industries, and others.
  • Promising Severe Asthma Therapies such as Verekitug (UPB-101), FB704A, TQC2731, Benralizumab, povorcitinib, CM326, and others.

 

Stay ahead with the most recent pipeline outlook for Severe Asthma. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Severe Asthma Approved Drugs

 

Severe Asthma Emerging Drugs

  • GSK3511294: GlaxoSmithKline

GSK 3511294, also known as depemokimab, is a long acting, interleukin-5 (IL-5) receptor antagonistic monoclonal antibody, being developed by GlaxoSmithKline, for the treatment of asthma. GSK3511294 is a humanized anti-interleukin (IL)-5 monoclonal antibody (mAb) engineered for extended half-life and improved IL-5 affinity versus other anti-IL-5 mAbs. Currently the drug is in Phase III stage of Clinical trial evaluation for the treatment of severe asthma.

  • BSI-045B: Biosion

BSI-045B is a high-affinity, humanized monoclonal antibody, targeting thymic stromal lymphopoietin (TSLP), a cytokine that is implicated in the pathogenesis of atopic dermatitis, asthma and other eosinophilic and Th2 immune-related diseases. Biosion’s collaboration partner – CTTQ, a China-based pharmaceutical company with rights to BSI-045B (TQC2731) for China development and commercialization, is currently conducting a Phase II clinical trial of BSI-045B in China for the treatment of severe uncontrolled asthma.

  • Mepolizumab: Bio-Thera Solutions

Mepolizumab is an interleukin-5 (IL-5) antagonist monoclonal antibody administered subcutaneously via syringe or autoinjector. It is currently indicated for several conditions: as an add-on maintenance treatment for adult and pediatric patients aged six years and older with severe asthma characterized by an eosinophilic phenotype; as an add-on maintenance treatment for adult patients aged 18 years and older with chronic rhinosinusitis with nasal polyps; for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis; and for the treatment of adult and pediatric patients aged 12 years and older with hypereosinophilic syndrome of at least six months’ duration without an identifiable non-hematologic secondary cause. Currently the drug is in Phase I stage of its clinical trial for the treatment of severe asthma.

 

Explore groundbreaking therapies and clinical trials in the Severe Asthma Pipeline. Access DelveInsight’s detailed report now! @ Severe Asthma Treatment Drugs

 

Severe Asthma Companies

Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier Biotherapeutics, Kymera Therapeutics, Suzhou Connect Biopharmaceuticals, Upstream Bio, Teva Branded Pharmaceutical Industries, and others.

 

Severe Asthma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

  • Oral
  • Intravenous
  • Subcutaneous
  • Parenteral
  • Topical

 

Severe Asthma Products have been categorized under various Molecule types such as

  • Recombinant fusion proteins
  • Small molecule
  • Monoclonal antibody
  • Peptide
  • Polymer
  • Gene therapy

 

Unveil the future of Severe Asthma Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight’s expert analysis @ Severe Asthma Market Drivers and Barriers

 

Scope of the Severe Asthma Pipeline Report

  • Coverage- Global
  • Severe Asthma Companies- Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier Biotherapeutics, Kymera Therapeutics, Suzhou Connect Biopharmaceuticals, Upstream Bio, Teva Branded Pharmaceutical Industries, and others.
  • Severe Asthma Therapies- Verekitug (UPB-101), FB704A, TQC2731, Benralizumab, povorcitinib, CM326, and others.
  • Severe Asthma Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Severe Asthma Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

Get the latest on Severe Asthma Therapies and clinical trials. Download DelveInsight’s in-depth pipeline report today! @ Severe Asthma Companies, Key Products and Unmet Needs

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Severe Asthma: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Severe Asthma– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. GSK3511294: GlaxoSmithKline
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. BSI-045B: Biosion
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. Mepolizumab: Bio-Thera Solutions
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. Drug name: Company name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Severe Asthma Key Companies
  21. Severe Asthma Key Products
  22. Severe Asthma- Unmet Needs
  23. Severe Asthma- Market Drivers and Barriers
  24. Severe Asthma- Future Perspectives and Conclusion
  25. Severe Asthma Analyst Views
  26. Severe Asthma Key Companies
  27. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09193216187
Address:304 S. Jones Blvd #2432,
City: Las Vegas
State: United States
Country: India
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Severe Asthma Pipeline 2024 | Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier Biotherapeutics, Kymera

The Sale of Elevator and Escalator Market in the US to Reach 40.1 Thousand Units by 2029 – Exclusive Research Report by Arizton

“U.S. Elevator and Escalator Market Research Report by Arizton”

According to Arizton’s latest research report, the US elevator and escalator market is growing at a CAGR of 2.87% during the forecast period.  

 

To Know More, Click: https://www.arizton.com/market-reports/united-states-elevator-and-escalator-market 

 

Report Summary  

Market Size by New Installations (2029): 40.1 Thousand Units 

Market Size by New Installations (2023): 33.8 Thousand Units 

CAGR – New Installations (2023-2029): 2.87% 

Market Size by Installed Base (2029): 1424.5 Thousand Units 

Market Size by Modernization (2023): USD 1.20 Billion 

Historic Year: 2020-2022 

Base Year: 2023 

Forecast Year: 2024-2029 

Segmentation by Carriage Type: Passenger and Freight 

Segmentation by Capacity: 2-15 Persons, 16-24 Persons, 25-33 Persons, and 34 Persons and Above 

Segmentation by End-User: Commercial, Residential, Industrial, and Others 

Segmentation by Machine Type: Hydraulic and Pneumatic, Machine Room Traction, Machine Room Less Traction, and Others

 

Stay ahead of the curve with Arizton’s exclusive subscription plan, offering in-depth analysis, market sizing, and growth forecasts for less than $900 per month—a significant value compared to individual report purchases. Click here: https://www.arizton.com/subscription        

 

Elevators are becoming more common in the building business as they become the primary form of transportation for persons looking to travel to higher floors within buildings, and they are especially beneficial to people with mobility issues. 

The US construction market was anticipated to grow by 7% in 2022, primarily due to increased demand for new homes and residential renovations. By 2025, residential buildings are expected to contribute more than $1 trillion to the economy. Population expansion, a greater need for cheap housing, and changing lifestyles that result in more individuals are a few causes driving the rise of the residential building business. Installing an elevator in residential sectors allows convenience and luxury. Home elevators have a lot of attractive features that can be sold as a benefit to the potential buyer. Elevators consume less time and are easier to move heavy and bulky objects. They are also helpful to children and older people facing challenges using stairs. Elevators reduce cases of common accidents such as falling down the stairs or children tripping over stair rails. 

 

Mergers and Acquisitions in the U.S. Elevator and Escalator Market 

  • Cibes Lift Group, a Swedish company, has acquired Area Access Inc., a Virginia-based distributor of vertical lifts. This acquisition expands Cibes’ presence in the U.S. market and enhances its ability to provide innovative solutions to customers nationwide. It is Cibes’ fourth addition in the U.S. and will be finalized by the first quarter of 2024. 

  • TEI Group, the largest independent vertical transportation company in the NYC metropolitan area, has announced its expansion into the U.S. Southeast by establishing a headquarters in Tampa, Florida. This move aims to extend TEI Group’s reach and services into the Southeastern region. 

  • PAPL Corp. revealed in February 2024 the establishment of U.S. subsidiary PAPL Inc. and Singapore subsidiary SINGAPORE PTE LTD. With 17 years of operations in India and the Middle East, these new subsidiaries signal a significant move toward the company’s future. 

  • Fort Lauderdale-based Axxiom Elevator expanded its Southwest footprint by acquiring Iron Hawk Elevator, based in Tucson, Arizona, and serving southern Arizona and western New Mexico. This acquisition, announced by financial advisors Maven Group on December 19, 2023, follows Axxiom’s acquisition of Arizona Elevator Services. 

 

Growing Visitors at Commercial Places to Drive the Demand for Escalator 

Escalators are widely used in densely populated shopping centers, airports, transit hubs, and hotels. With 83% of Americans residing in urban areas in 2021, a significant increase from 64% in 1950, this trend is expected to continue, with an estimated 89% projected to live in metropolitan regions by 2050. New York City, the largest urban area with 8.8 million residents, faces increasing congestion, especially in commercial areas. Escalators offer efficient movement without much waiting time, facilitating the smooth flow of people. They also allow pedestrians to walk if they’re in a hurry or case of breakdowns. 

However, escalator safety remains a concern. Many injuries result from user negligence, particularly children playing unsupervised near escalators or moving walkways. The use of strollers on escalators is especially unsafe. About 75% of escalator injuries stem from falls, while 20% involve entanglement incidents, often due to loose clothing or footwear. Compared to elevator incidents, escalator accidents are more prevalent and concerning. 

 

The U.S. Elevator and Escalator Market Dynamics 

Drivers 

  • Increasing accommodation building approvals are expected to drive demand for elevators and escalators as the U.S. sees a surge in hotel openings, led by New York City and followed by Atlanta.  

  • The trend of office-to-residential conversions is further propelling the residential elevator segment, with cities like Houston and Boston offering incentives to convert surplus office space into housing, supported by initiatives such as NYC’s Office Conversion Accelerator, to expedite the conversion process and address housing shortages. 

  • Growing numbers of building permits and the construction of high-rise structures sought after, especially within the residential domain. 

Opportunities  

  • Elevator maintenance traditionally depends on experienced technicians’ ability to detect issues through trained hearing, which modern technicians may lack. Otis has introduced machine learning with Tune, analyzing elevator acoustic data to identify maintenance needs, and improving efficiency and accuracy. 

  • Addressing the rising demand for housing and the need to speed up construction, prefabricated modules are becoming popular and is reshaping the construction sector. 

Restraints 

  • Rising maintenance costs and labor shortages overcharge customers, delay repairs, and challenge the availability of experienced workers and components. 

  • Declining housing disrupts construction schedules, affecting project timelines and completion. 

  • Component scarcity in older elevators hampers service timelines, while project delays due to inspections compound construction challenges. 

 

Buy this Research @ https://www.arizton.com/market-reports/united-states-elevator-and-escalator-market 

 

Key Vendors 

  • Otis 

  • TK Elevator 

  • Schindler 

  • KONE 

  • Mitsubishi Electric 

  • Hitachi 

  • Hyundai Elevator 

  • Fujitec 

  • MEI Total Elevator Solutions 

  • Wurtec 

  • Delaware Elevator 

  • Day Elevator and Lift 

  • Liberty Elevator 

  • TEI Group 

  • AVT Beckett 

  • Colley Elevator 

  • Champion Elevator 

  • Access Elevator & Lifts, Inc. 

  • Godwin Elevator 

  • Potomac Elevator Company 

  • Action Elevator Company 

  • Advanced Elevator 

 

Elevator Market Segmentation by 

  • Machine Type 

  • Hydraulic and Pneumatic 

  • Machine Room Traction 

  • Machine Room Less Traction 

  • Others  

  • Climbing 

  • Elevators 

  • Industrial Elevators 

  • Carriage Type 

  • Passenger 

  • Freight  

  • Capacity 

  • 2-15 Persons 

  • 16-24 Persons 

  • 25-33 Persons 

  • 34 Persons and Above  

  • End-User 

  • Commercial 

  • Residential 

  • Industrial 

  • Others  

  • Public Transit 

  • Institutional 

  • Infrastructural 

 

Escalator Market Segmentation by 

  • Product Type 

  • Parallel 

  • Multi Parallel 

  • Walkway 

  • Crisscross 

  • End-User 

  • Public Transit 

  • Commercial 

  • Others 

  • Institutional Sector 

  • Infrastructure 

  • Industrial 

 

Key Questions Answered in the Report: 

How big is the U.S. elevator and escalator market? 

What will be the growth rate of the U.S. elevator and escalator market? 

What are the key opportunities in the U.S. elevator and escalator market? 

What is the number of installed bases in the U.S. elevator and escalator market in 2023? 

What are the key U.S. elevator and escalator market players? 

 

Check Out Some of the Top Selling Reports of Your Interest:     

GCC Elevator and Escalator Market – Size & Growth Forecast 2024-2029 

https://www.arizton.com/market-reports/gcc-elevator-and-escalator-market 

UAE Elevator and Escalator Market – Size & Growth Forecast 2024-2029 

https://www.arizton.com/market-reports/uae-elevator-and-escalator-market 

 

Why Arizton?                                

100% Customer Satisfaction                                

24×7 availability – we are always there when you need us                                

200+ Fortune 500 Companies trust Arizton’s report                                

80% of our reports are exclusive and first in the industry                                

100% more data and analysis                                

1500+ reports published till date              

Post-Purchase Benefit                            

1hr of free analyst discussion                            

10% off on customization         

 

About Us:                                                                     

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                                   

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                                    

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                                          

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1-312-235-2040 / +1 302 469 0707
Country: United States
Website: https://www.arizton.com/market-reports/united-states-elevator-and-escalator-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Sale of Elevator and Escalator Market in the US to Reach 40.1 Thousand Units by 2029 – Exclusive Research Report by Arizton

Embedded Finance Market Size Analysis And Growing Trends By Segmentations, Top Companies, Geographical Expansion, Future Development & Forecast -2029

“Stripe, Inc. (US), PayPal Holdings, Inc. (US), Amazon.com, Inc. (US), Plaid, Inc. (US), Klarna Bank AB (Sweden), FIS (US), Visa Inc. (US), Cross River Bank (US), Zeta Services Inc. (US), Marqeta, Inc. (US), Wise Payments Limited (UK), Goldman Sachs (UK), JPMorgan Chase & Co. (US).”
Embedded Finance Market Size, Share, Growth Analysis, By Type (embedded payments, embedded lending, embedded insurance, embedded wealth management), Business Model, Industry (retail & eCommerce, healthcare) – Global Forecast to 2029.

The global embedded finance market size is projected to grow from USD 115.8 billion in 2024 to USD 251.5 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 16.8%. The growth in the market is due to the enhanced demand for hybrid financial services where clients and users can easily access financial solutions in non-financial domains. Similarly, developing digital systems and government support further boost the growth of embedded finance solutions in different industries.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=126584658  

The embedded finance market is experiencing a massive disruption because of the development of technologies such as API, AI, blockchain, etc. This capability allows companies to incorporate financial services into their platforms, delivering consistent and unique solutions. Furthermore, demand for new complex, value-added, readily available services that can be offered in real-time has pressured firms in almost all industries to embrace embedded finance. This shift helps non-financial firms to provide banking, lending, insurance, and payment services, which fortifies customer relations and generates more revenues. This market is divided into segments based on different aspects, such as the type, business model, and industry. Type includes solutions such as embedded payments, embedded lending, embedded insurance, embedded investment/wealth management, and others such as issuance and deposits. The business model includes both B2B and B2C. The industry segment focuses on retail & eCommerce, healthcare, education, telecom, transportation, mobility and logistics, travel & hospitality, and other industries, namely real estate, energy, media & entertainment, and agriculture. These segments collectively offer a comprehensive overview of the evolving embedded finance landscape and its potential business implications.

“Based on industry, retail & eCommerce sector to hold the largest market size during the forecast period.”

The research identified several drivers that would make the retail and e-commerce sector the most significant market for embedded finance throughout the forecast period, including the steady growth in online purchasing coupled with the rising number of digital consumers requires effective financial services integrated into the e-commerce platforms; BNPL products increase consumers’ purchasing capacity, leading to increased spending. Personalization capabilities enable retailers to offer customized financial products to their customers, enhancing satisfaction and loyalty. Secure payment gateways and other algorithms in fintech underline smooth transaction processes, leading to higher consumer confidence. An omnichannel approach that integrates both online and offline experiences has financial services that help improve the shopping experience. Growing cooperation between fintech and retailers helps to achieve significant integration and compliance with the requirements to introduce new services. At the same time, the growth of mobile commerce enhances the demand for integrated mobile payments. Collectively, these factors explain the large market size of the retail and e-commerce segment in the embedded finance market during the forecast period.

“Based on the business model, the B2C model is expected to hold a higher growth rate during the forecast period.”

The B2C model for embedded finance is expected to experience tremendous growth primarily because of the rising customer expectations for integrated and omnichannel financial solutions. The development of digital channels and e-commerce fuels the need for broader implementation. Innovation experiences in fintech, APIs, and AI, for instance, have helped ease integration, lowering entry barriers. Moreover, the strategic B2C model increases customer loyalty and customer retention since it provides them with individualized financial services, thus building lasting partnerships. It also widens the market since consumers who used to be locked out from accessing financial facilities due to various factors can access business ventures. Favorable economic and demographic indicators, such as improved disposable income, especially in emerging markets, as well as enhanced access to the Internet, have also boosted the demand for integrated financial services. These factors have made it evident that the B2C embedded finance model will likely realize faster growth during the forecast period under consideration.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=126584658  

Unique Features in the Embedded Finance Market

Direct integration of financial services into non-financial platforms and services is known as embedded finance. Businesses may now offer financial goods like loans, investments, payments, and insurance inside of their current ecosystems—which may include ride-sharing applications, e-commerce sites, or even healthcare services—thanks to this smooth connection. Businesses may offer a more unified user experience, retaining clients inside their ecosystem and raising engagement, by integrating these financial services.

By offering financial services when needed, embedded finance has the potential to improve the client experience. For example, clients can purchase insurance instantly while booking travel or have the option to pay for it later at checkout. Financial services become easier to get and more convenient as a result of the transaction friction being reduced and the customer path being simplified.

APIs (Application Programming Interfaces) are fundamental to the embedded finance market. They enable different platforms to communicate and integrate seamlessly. Fintech companies often provide APIs that allow businesses to incorporate various financial services into their platforms without needing to develop these services from scratch. This API-driven approach accelerates innovation and time-to-market for new financial products.

Embedded finance leverages vast amounts of data generated by non-financial platforms to offer personalized financial services. By analyzing user behavior, spending patterns, and other relevant data, companies can tailor financial products to individual needs. This data-driven personalization helps in offering relevant financial solutions, improving customer satisfaction, and increasing the adoption of financial products.

For non-financial companies, embedded finance opens up new revenue streams. By integrating financial services, these companies can earn commissions, fees, or a share of the interest on loans and credit products offered through their platforms. This diversification of revenue is particularly valuable in industries with thin margins, as it enhances profitability without significant additional investment.

Major Highlights of the Embedded Finance Market

The market for embedded finance is expanding quickly due to the growing incorporation of financial services into non-financial platforms. The emergence of digital ecosystems, technological breakthroughs, and shifting consumer preferences—which call for easy and convenient financial solutions—are the main drivers of this growth. The growth of fintech companies and their inventive solutions is another factor contributing to the market’s expansion.

Various sectors’ ecosystems are expanding rapidly as a result of embedded finance. Financial services are being integrated by non-financial businesses to improve their value propositions. Examples of these businesses include social media networks, ride-sharing services, and e-commerce platforms. Through this development, these businesses are able to provide comprehensive solutions that cater to a variety of client needs, which in turn increases customer engagement and loyalty.

A wide range of financial products is being embedded into non-financial platforms, including payments, lending, insurance, and investment services. This diversity enables companies to tailor their offerings to meet the specific needs of their customers. For example, buy-now-pay-later options are becoming popular in retail, while on-demand insurance products are gaining traction in the travel and gig economy sectors.

One of the most significant highlights of embedded finance is its ability to enhance the user experience. By offering financial services directly within existing platforms, customers can enjoy a seamless and integrated experience. This reduces the need for multiple accounts or applications and simplifies financial transactions, leading to higher customer satisfaction and retention.

APIs play a crucial role in the development of embedded finance solutions. They enable the integration of financial services into various platforms quickly and efficiently. Fintech companies provide APIs that allow businesses to access and offer financial products without having to develop them internally. This API-driven approach fosters innovation and accelerates the deployment of new financial services.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=126584658  

Top Companies in the Embedded Finance Market

Key and innovative vendors in the embedded finance market include Stripe, Inc. (US), PayPal Holdings, Inc. (US), Amazon.com, Inc. (US), Plaid, Inc. (US), Klarna Bank AB (Sweden), FIS (US), Visa Inc. (US), Cross River Bank (US), Zeta Services Inc. (US), Marqeta, Inc. (US), Wise Payments Limited (UK), Goldman Sachs (UK), JPMorgan Chase & Co. (US), Alipay+ (China), Unit Finance Inc. (US), Solaris SE (Germany), Parafin, Inc. (US), Belvo (Mexico), Kasko Ltd. (UK), Tint Technologies Inc. (US), Mezu, Inc. (US), Fortis Payment Systems (US), Additiv AG (Switzerland), Galileo Financial Technologies, LLC (US), Trevipay (US). The market players have adopted various strategies to strengthen their market position. Organic and inorganic strategies have helped the market stakeholders globally by providing a comprehensive suite of embedded finance solutions, boosting innovation through research and development initiatives, establishing strategic partnerships with key industry stakeholders, and facilitating mergers and acquisitions to strengthen their technological capabilities and market presence.

STRIPE, INC.

Stripe is a global fintech company that offers payment software solutions for businesses and people to make and receive payments via the Internet or through its mobile applications. The company creates software for the handling of online debit and credit card transactions. Stripe’s support services are divided into application support, sales support, developer support, and analytics support. Its product offerings include Atlas, Billing, Capital, Checkout, Climate, Connect, Corporate Card, Data Pipeline, Elements, Financial Connections, Identity, Invoicing, Payment Links, and many others. As for the company’s presence, Stripe is in San Francisco, Dublin, Paris, London, Ireland, and Tokyo, which arranges its presence in North America, Europe, and Asia. According to the International Labour Organization, the company has 8,016 employees.

PAYPAL HOLDINGS, INC.

PayPal Holdings, Inc. is a global and American-based company that offers an online financial platform that simplifies payments and commerce with merchants and consumers globally. The company only aims at reducing the financial barriers to financial services, enhancing users’ and society’s financial well-being, and expanding access to capital, and economic opportunity for all PayPal consumers, merchants, and other businesses globally. The company collects revenue from two segments: revenues from the actual transaction and quantitative revenues from other related value-added services. Their goal is to enable merchants and consumers to manage and move their money anywhere in the world in the markets we serve, anytime, on any platform, and using any device when sending payments or getting paid, including person-to-person (“P2P”) payments. PayPal believes that effective management of non-financial risks and opportunities, including environmental, social, and governance (“ESG”) topics, helps to create value for stakeholders and deliver on mission and strategy. According to their annual report for the year ended 2023, the revenue reached USD 29,771 billion. The company has 27,200 employees who are actively employed in the company. PayPal is a global company with a presence in different regions, such as Europe, the Middle East, Asia and the Pacific, and North and Latin America.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/embedded-finance-market-126584658.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Embedded Finance Market Size Analysis And Growing Trends By Segmentations, Top Companies, Geographical Expansion, Future Development & Forecast -2029

Intelligent Process Automation Market Top Trends, Global Size, Share, Emerging Technologies, Applications, and Forecast 2027

“Atos (France), IBM (US), Genpact (US), HCL Technologies (India), Pegasystems (US), Blue Prism (UK), Capgemini (France), CGI (Canada), Nice (Israel), Cognizant (US), Infobip (England), Accenture (Ireland), Infosys (India), TCS (India), Tech Mahindra (India).”
Intelligent Process Automation Market by Component, Technology, Application, Business Function, Deployment Mode (On-premises, Cloud), Organization Size (Large Enterprises, SMEs), Vertical and Region – Global Forecast to 2027.

The global Intelligent Process Automation Market size is expected to grow USD 13.6 billion in 2022 to USD 25.9 billion by 2027, at a Compound Annual Growth Rate (CAGR) of 13.8%  during the forecast period.The supply chain function has been greatly benefiting organizations. However, there are areas within the supply chain function where slow and manual processes exist. The globalization of business has led enterprises to deploy the IPA solution for optimizing their supply chain processes.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=23417145  

Operations and supply chain segment to grow at the highest CAGR during the forecast period

Operations & supply chain management is the design, operation, and improvement of the systems that create and deliver the firm’s primary products and services. It is concerned with the management of the entire system that produces a product or delivers a service. Automation enables organizations to capture and process orders effectively, starting right from the initial phase of planning, configuring, pricing, and order delivery. In today’s digital age, customer experience plays a vital role as a differentiator among service providers. IPA in the field of operations & supply chain is one of the largest and major applications. Analytics, digital assistants, and automation are the major applications of IPA in operations. AI helps identify the relevance of personalized online content and other recommendations or targeted advertising. AI helps managers visualize programmatic trends and opportunities and focus on building a profound supply chain.

BFSI segment is expected to grow at a higher CAGR during the forecast period

In the BFSI industry, multiple systems are linked with each other by interfaces to enable the flow of transaction-related data. Automation solutions control and monitor these interfaces to ensure seamless execution of transactions and fix bottlenecks in workflows. These solutions improve the accuracy and efficiency of various processes and assist in regulatory and compliance reporting by collating data from multiple systems and conducting validation checks to prepare information for detailed analysis. Most banks are increasingly deploying intelligent automation solutions to enhance productivity, improve cost savings, and improve customer experience. These solutions are also deployed to increase process efficiency and enable employees to focus on high-value projects.

Asia Pacific region to record the highest CAGR in the Intelligent process automation market

Companies operating in this region benefit from flexible economic conditions, industrialization, and globalization-motivated policies of governments, as well as the expanding digitalization in the region. Enterprises have readily adopted robotic process automation solutions in the past few years, and the trend is expected to gain traction with the growing presence of intelligent process automation providers, such as Blue Prisms geographical expansion in the region. Such factors are expected to boost the growth of the IPA market.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=23417145  

Unique Features in the Intelligent Process Automation Market

Intelligent Process Automation (IPA) uniquely combines multiple advanced technologies to optimize and automate business processes. It integrates artificial intelligence (AI), machine learning (ML), robotic process automation (RPA), natural language processing (NLP), and cognitive computing. This convergence of technologies enables IPA to handle complex tasks that go beyond traditional automation, allowing for more sophisticated and adaptive process automation.

IPA significantly enhances decision-making capabilities within organizations. By leveraging AI and ML, IPA systems can analyze vast amounts of data in real-time, identify patterns, and provide actionable insights. This allows businesses to make informed decisions quickly, improving efficiency, reducing errors, and enabling proactive management of operations.

A key feature of IPA is its ability to improve customer experience by automating customer interactions and personalizing services. Through the use of NLP and AI, IPA can understand and respond to customer queries, automate support tasks, and provide tailored recommendations. This not only speeds up response times but also ensures a more consistent and high-quality customer experience.

IPA enables end-to-end process automation, which means it can automate entire workflows rather than just individual tasks. This holistic approach ensures that processes are streamlined from start to finish, reducing bottlenecks and improving overall operational efficiency. By automating end-to-end processes, organizations can achieve significant time and cost savings.

One of the standout features of IPA is its scalability and flexibility. IPA solutions can be scaled up or down based on the organization’s needs and can be adapted to different industries and business functions. This flexibility ensures that IPA can be customized to fit specific process requirements, making it a versatile solution for a wide range of applications.

Major Highlights of the Intelligent Process Automation Market

The market for intelligent process automation (IPA) is expanding quickly and is being widely used in many different industries. Businesses are realizing more and more how valuable IPA is for raising overall productivity, cutting expenses, and optimizing operational efficiency. The quick developments in artificial intelligence (AI), machine learning, and robotic process automation, along with the growing demand from organizations for digital transformation, are the main drivers of this rise.

Prominent developments in technology are a major selling point for the IPA market. New developments in natural language processing, artificial intelligence, machine learning, and cognitive computing are propelling the creation of increasingly complex and potent IPA solutions. These developments provide organizations state-of-the-art automation solutions by enabling IPA to manage complicated activities, make data-driven decisions, and continually learn and improve.

One of the most notable highlights of IPA is its ability to significantly enhance operational efficiency. By automating repetitive and manual tasks, IPA frees up human resources to focus on higher-value activities. This leads to faster processing times, reduced error rates, and overall improved efficiency in business operations. Organizations can achieve substantial cost savings and productivity gains through IPA implementation.

IPA is playing a crucial role in improving customer experience. By leveraging AI and natural language processing, IPA can automate customer interactions, provide personalized responses, and offer real-time support. This results in faster resolution of customer queries, higher satisfaction levels, and a more consistent and high-quality customer experience.

A major highlight of the IPA market is its ability to seamlessly integrate with existing IT systems and applications. This compatibility ensures that organizations can implement IPA without significant disruptions to their current operations. The smooth integration capabilities of IPA facilitate a more cohesive and interconnected IT environment, enhancing overall business agility.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=23417145  

Top Companies in the Intelligent Process Automation Market

The major vendors covered in the intelligent process automation Market are Atos (France), IBM (US), Genpact (US), HCL Technologies (India), Pegasystems (US), Blue Prism (UK), Capgemini (France), CGI (Canada), Nice (Israel), Cognizant (US), Infobip (England), Accenture (Ireland), Infosys (India), TCS (India), Tech Mahindra (India), UIPath (US), Wipro (India), Xerox (US), Happiest Minds (India), WorkFusion (US), Automation Anywhere (US), Virtual Operations (UK), Hive (US), HyperScience (US), Laiye (China), Cognigy (Germany), Jiffy.ai (US), Infinitus (US), ElectroNeek (US), Snorkel AI (US), Vianai (US), Kryon (Israel), Rossom (UK), Autologyx (UK), Automation Edge (US).

These players have adopted various growth strategies, such as partnerships, business expansions, mergers and acquisitions, agreements, and collaborations, new product launches to expand their presence in the intelligent process automation market. Partnerships and new product launches have been the most adopted strategies by major players from 2019 to 2021, which helped them innovate their offerings and broaden their customer base.

Atos was founded in 1997 and is headquartered in Bezons, Paris (France). The company offers infrastructure & data management, business & platform, cloud operations, big data, and cybersecurity solutions to customers across the globe. The company offers automation and robotics solutions, which help organizations benefit from the automated process. Atos provides solutions to customers in various industry verticals, including aerospace, defense, banking, insurance, telecommunication, manufacturing, life sciences, transport, media, and energy. As of 2021, it had about 110,000 employees, which is spread in over 73 countries. Atos is the global leader in secure and decarbonized digital, with a range of market-leading digital solutions and consultancy services, digital security, decarbonization offerings, and an end-to-end partnership approach. It is a leader in cloud and digital workplaces with capabilities, such as best-in-class computing power and the Quantum Learning Machine. Atos is helping design the future of the information space. It serves industry verticals, such as financial services & insurance, healthcare & life sciences, manufacturing, public sector & defense, resources & services, and telecommunications & media.

IBM was founded in 1911 and is headquartered in New York, US. The company is one of the leading providers of cloud platform services and cognitive solutions. IBM works across domains, such as Watson, cloud, IT infrastructure, security, services, and research. It operates in more than 175 countries and caters to verticals across the globe. IBM caters to diverse segments, such as cloud and cognitive software, global business services, global technology services, systems, and global financing. The company offers an extensive set of products and solutions across various categories, such as cloud cognitive, commerce, analytics, IoT, mobile, and security. It also caters to various services, such as Customer Relationship Management (CRM), enterprise content management, Human Capital Management (HCM), financial management, Supply Chain Management (SCM), asset recovery, application, outsourcing, and software.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/intelligent-process-automation-market-23417145.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Intelligent Process Automation Market Top Trends, Global Size, Share, Emerging Technologies, Applications, and Forecast 2027

Thyroid Cancer Pipeline 2024 | AffyImmune Therapeutics, Suzhou Zelgen Biopharmaceuticals, Bristol-Myers Squibb, Suzhou NeuPharma, AstraZeneca, Verastem Oncology, Thryv Therapeutics

DelveInsight’s, “Thyroid Cancer Pipeline Insight 2024” report provides comprehensive insights about 50+ companies and 51+ pipeline drugs in Thyroid Cancer pipeline landscape. It covers the Thyroid Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Discover the latest drugs and treatment options in the Thyroid Cancer Pipeline. Dive into DelveInsight’s comprehensive report today! @ Thyroid Cancer Pipeline Outlook

 

Key Takeaways from the Thyroid Cancer Pipeline Report

  • July 2024:- Istituti Clinici Scientifici Maugeri SpA– This window of opportunity trial is studying a checkpoint inhibitor agent to treat differentiated thyroid cancer in a neoadjuvant setting. A checkpoint inhibitor is a compound aimed at restoring tumor immunosurveillance. The name of this agent is pembrolizumab.
  • July 2024:- ModeX Therapeutics, An OPKO Health Company- A Phase 1/2a, Multicenter, First-in-human, Open-label Clinical Trial Evaluating MDX2001 Monotherapy in Patients With Advanced Solid Tumors. This study consists of Phase 1a dose escalation, Phase 1b dose expansion in a single indication, and Phase 2a expansion in a single indication. This study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.
  • DelveInsight’s Thyroid Cancer pipeline report depicts a robust space with 50+ active players working to develop 51+ pipeline therapies for Thyroid Cancer treatment.
  • The leading Thyroid Cancer Companies such as AffyImmune Therapeutics, Suzhou Zelgen Biopharmaceuticals, Bristol-Myers Squibb, Suzhou NeuPharma, AstraZeneca, Verastem Oncology, Thryv Therapeutics, Molecular Targeting Technologies, Chimerix, Codiak BioSciences, LeadArtis, Tyra Biosciences, Roche, Sichuan Kelun-Biotech Biopharmaceutical, Advenchen Laboratories, and others.
  • Promising Thyroid Cancer Therapies such as Selpercatinib, Cabozantinib, Vandetanib, E7080 Capsule, Lenvatinib (DTC Cohort), Irofulven + capecitabine, XL184, AL2846 Capsule, and others.

 

Stay ahead with the most recent pipeline outlook for Thyroid Cancer. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Thyroid Cancer Approved Drugs

 

Thyroid Cancer Emerging Drugs

  • rhTSH: Suzhou Zelgen Biopharmaceuticals

Recombinant human TSH (rhTSH) was developed to provide TSH stimulation without the requirement for THST withdrawal and the resultant metabolic disturbance, and without the drawbacks associated with the use of bovine TSH. The drug is currently being evaluated under Phase III clinical trial for the treatment of patients with thyroid cancer.

  • Nivolumab: Bristol-Myers Squibb

Nivolumab is a human immunoglobulin G4 (IgG4) monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with PD-L1 and PD-L2, releasing PD-1 pathway-mediated inhibition of the immune response, including the anti-tumor immune response. The drug is currently being evaluated under Phase II clinical trial for the treatment of patients with thyroid cancer.

  • RX208: Suzhou NeuPharma

RX208 is a potential “best-in-class” BRAF V600E inhibitor with a proprietary novel chemical structure that is different from other marketed BRAF inhibitors. It exhibited high bioavailability and excellent anti-tumor efficacy in preclinical studies. Early clinical data demonstrated preliminary efficacy and good safety and tolerability in patients with cancer, warranting further clinical development. The drug is currently being evaluated under Phase I/II clinical trial for the treatment of patients with thyroid cancer.

  • AIC100: AffyImmune Therapeutics

AffyImmune’s lead product, AIC100, is an affinity-tuned, ICAM-1 targeted, third generation CAR T cell therapy. AIC100’s CAR has an affinity to ICAM-1 similar to the affinity between naturally-occurring T cells and their targets, which is much lower than most CARs used to date and reduces on-target off-tumor toxicities. AIC100 also expresses SSTR2 for real-time monitoring of CAR T cell distribution and activity. Preclinical studies demonstrate that AIC100 induces robust and enduring tumor eradication without toxicity-related relapse or fatality in various solid tumor models. Studies also suggest the potential for combination with anti-PD-1 therapies. The drug is currently being evaluated under Phase I clinical trial for the treatment of patients with Thyroid Cancer.

 

Explore groundbreaking therapies and clinical trials in the Thyroid Cancer Pipeline. Access DelveInsight’s detailed report now! @ Thyroid Cancer Treatment Drugs

 

Thyroid Cancer Drugs and Companies

  • Rosiglitazone: Exelixis
  • Lenvatinib: Eisai Limited
  • Ifosfamide: Merck Sharp & Dohme LLC

 

Thyroid Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

  • Intravenous
  • Subcutaneous
  • Oral
  • Intramuscular

 

Thyroid Cancer Products have been categorized under various Molecule types such as

  • Monoclonal antibody
  • Small molecule
  • Peptide

 

Unveil the future of Thyroid Cancer Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight’s expert analysis @ Thyroid Cancer Market Drivers and Barriers

 

Scope of the Thyroid Cancer Pipeline Report

  • Coverage- Global
  • Thyroid Cancer Companies such as AffyImmune Therapeutics, Suzhou Zelgen Biopharmaceuticals, Bristol-Myers Squibb, Suzhou NeuPharma, AstraZeneca, Verastem Oncology, Thryv Therapeutics, Molecular Targeting Technologies, Chimerix, Codiak BioSciences, LeadArtis, Tyra Biosciences, Roche, Sichuan Kelun-Biotech Biopharmaceutical, Advenchen Laboratories, and others.
  • Thyroid Cancer Therapies- Selpercatinib, Cabozantinib, Vandetanib, E7080 Capsule, Lenvatinib (DTC Cohort), Irofulven + capecitabine, XL184, AL2846 Capsule, and others.
  • Thyroid Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Thyroid Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

Get the latest on Thyroid Cancer Therapies and clinical trials. Download DelveInsight’s in-depth pipeline report today! @ Thyroid Cancer Companies, Key Products and Unmet Needs

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Thyroid Cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Thyroid Cancer– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. rhTSH: Suzhou Zelgen Biopharmaceuticals
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. Nivolumab: Bristol-Myers Squibb
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. AIC100:Affyimmune Therapeutics
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. Drug name: Company name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Thyroid Cancer Key Companies
  21. Thyroid Cancer Key Products
  22. Thyroid Cancer- Unmet Needs
  23. Thyroid Cancer- Market Drivers and Barriers
  24. Thyroid Cancer- Future Perspectives and Conclusion
  25. Thyroid Cancer Analyst Views
  26. Thyroid Cancer Key Companies
  27. Appendix 

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432,
City: Las Vegas
State: United States
Country: India
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Thyroid Cancer Pipeline 2024 | AffyImmune Therapeutics, Suzhou Zelgen Biopharmaceuticals, Bristol-Myers Squibb, Suzhou NeuPharma, AstraZeneca, Verastem Oncology, Thryv Therapeutics